Conţinutul numărului revistei |
Articolul precedent |
Articolul urmator |
1182 2 |
Ultima descărcare din IBN: 2021-07-10 16:23 |
SM ISO690:2012 MUSTEAŢĂ, Vasile. Aspectele epidemiologice şi manageriale actuale ale leucemiei mieloide cronice. In: Curierul Medical, 2011, nr. 3(321), pp. 67-71. ISSN 1875-0666. |
EXPORT metadate: Google Scholar Crossref CERIF DataCite Dublin Core |
Curierul Medical | ||||||
Numărul 3(321) / 2011 / ISSN 1875-0666 | ||||||
|
||||||
Pag. 67-71 | ||||||
|
||||||
Descarcă PDF | ||||||
Rezumat | ||||||
Updated Epidemiologic and Management Aspects of Chronic Myeloid Leukemia
Chronic myeloid leukemia is a clonal myeloproliferative disorder resulting from the stem cell neoplastic transformation caused by translocation between
the long arms of chromosomes 22 and 9. Chronic myeloid leukemia accounts 15–20% of leukemias in adults. This myeloproliferative malignancy occurs
mostly in workable population with the age of 25–50 years old. Male: female ratio may reach 1.4:1. A higher incidence of chronic myeloid leukemia is
registered among persons heavily exposed to radiation, including survivors of the atomic bomb blasts in Japan and patients undergoing radiotherapy.
The contemporary management of CML diversifies the diagnostic and treatment options in regard with the level of medical assistance. Glivec®
International Patient Assistance Program (GIPAP) is one of the most generous and far-reaching patient assistance programs ever developed for cancer
therapy, axed on the insurance of treatment with Imatinib mesylate of different malignant neoplasms. |
||||||
Cuvinte-cheie chronic myeloid leukemia, epidemiology, management, level of medical assistance |
||||||
|